Author

Meihua Lin

Institutions: First Affiliated Hospital Zhejiang University, Zhejiang University

Observed institutions: First Affiliated Hospital Zhejiang University, Zhejiang University

ORCID: 0000-0002-4122-0830

Observed ORCID: 0000-0002-4122-0830

OpenAlex ID: A5143988134

Supplementary Table S3 from Phase I Trial of GPC3-Targeted TCR Fusion Construct, CT0180, in Patients with Advanced Hepatocellular Carcinoma

2026 · Xuqi Sun, Wanwan Gao, et al.

Supplementary Table S4 from Phase I Trial of GPC3-Targeted TCR Fusion Construct, CT0180, in Patients with Advanced Hepatocellular Carcinoma

2026 · Xuqi Sun, Wanwan Gao, et al.

Data from Phase I Trial of GPC3-Targeted TCR Fusion Construct, CT0180, in Patients with Advanced Hepatocellular Carcinoma

2026 · Xuqi Sun, Wanwan Gao, et al.

Supplementary Table S1 from Phase I Trial of GPC3-Targeted TCR Fusion Construct, CT0180, in Patients with Advanced Hepatocellular Carcinoma

2026 · Xuqi Sun, Wanwan Gao, et al.

Supplementary Table S2 from Phase I Trial of GPC3-Targeted TCR Fusion Construct, CT0180, in Patients with Advanced Hepatocellular Carcinoma

2026 · Xuqi Sun, Wanwan Gao, et al.

Supplementary material 1 from Phase I Trial of GPC3-Targeted TCR Fusion Construct, CT0180, in Patients with Advanced Hepatocellular Carcinoma

2026 · Xuqi Sun, Wanwan Gao, et al.

Phase I Trial of GPC3-Targeted TCR Fusion Construct, CT0180, in Patients with Advanced Hepatocellular Carcinoma

2026 · Xuqi Sun, Wanwan Gao, et al. · Clinical Cancer Research

Works count: 7

Citation count:

H-index:

I10-index: